Lipella Pharmaceuticals Files 8-K
Ticker: LIPO · Form: 8-K · Filed: Dec 27, 2024 · CIK: 1347242
| Field | Detail |
|---|---|
| Company | Lipella Pharmaceuticals Inc. (LIPO) |
| Form Type | 8-K |
| Filed Date | Dec 27, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Lipella Pharma filed an 8-K on 12/27/24 for 'other events' - need more info.
AI Summary
Lipella Pharmaceuticals Inc. filed an 8-K on December 27, 2024, reporting other events. The company, incorporated in Delaware, has its principal executive offices in Pittsburgh, PA. The filing does not contain specific details about the nature of the 'other events' or any associated financial figures.
Why It Matters
This filing indicates a material event has occurred for Lipella Pharmaceuticals, requiring public disclosure. Investors should look for subsequent filings or press releases for details.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, creating uncertainty about the nature and impact of the reported event.
Key Players & Entities
- Lipella Pharmaceuticals Inc. (company) — Registrant
- December 27, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Pittsburgh, PA (location) — Principal executive office
- (412) 894-1853 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' being reported.
When was this 8-K filing submitted?
This 8-K filing was submitted on December 27, 2024.
What is the principal executive office address for Lipella Pharmaceuticals Inc.?
The principal executive office is located at 7800 Susquehanna St., Suite 505, Pittsburgh, PA 15208.
What is the company's state of incorporation?
Lipella Pharmaceuticals Inc. is incorporated in Delaware.
What is the registrant's telephone number?
The registrant's telephone number is (412) 894-1853.
Filing Stats: 429 words · 2 min read · ~1 pages · Grade level 11.8 · Accepted 2024-12-27 16:05:28
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share LIPO The Nasdaq Stock Mar
Filing Documents
- g084619_8k.htm (8-K) — 30KB
- 0001753926-24-002162.txt ( ) — 201KB
- lipo-20241227.xsd (EX-101.SCH) — 3KB
- lipo-20241227_lab.xml (EX-101.LAB) — 33KB
- lipo-20241227_pre.xml (EX-101.PRE) — 22KB
- g084619_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 27, 2024 Lipella Pharmaceuticals Inc. By: /s/ Jonathan Kaufman Name: Jonathan Kaufman Title: Chief Executive Officer